EJHP Podcasts from the 18th Congress of the EAHP

The European Journal of Hospital Pharmacy (EJHP) recorded a number of podcast interviews with key speakers and seminar facilitators at the 18th Congress of the EAHP, held in Paris from 13th to 15th March 2013.

The theme of the Congress was "Improving patient outcomes: a shared responsibility".

You can listen freely to all nine podcasts by clicking the 'Find out more' button or select some of the highlights from the list below. If you missed the Congress, then it's definitely worth catching up with all the latest in hospital pharmacy.

Podcasts: Highlights from Speakers and seminar participants

Related to the Congress, editors and staff from EJHP spoke to the following speakers and seminar participants in order to gain further insights to the topics and themes presented:

■ Dr Fiona Reynolds in relation to her keynote speech on the establishment and use of Multi-Disciplinary Teams (MDT) in hospitals

■ Jorn Herrstedt, professor in clinical oncology, Odense University Hospital, Denmark and João Oliveira, medical director, Instituto Portugues de Oncologia, Lisbon about team challenges in cancer care

■ David Gerrett of the UK NHS Commissioning Board and Joanna Correa West, medicines management nurse, Birmingham Children's Hospital about inter-professional learning

■ Jean-Hughes Dalle, professor in pediatrics, Robert-Debré Hospital, Paris, Julie Rouprêt-Serzec, clinical pharmacist, Robert-Debré Hospital, and Anthony Sinclair, director of pharmacy, Birmingham Children's Hospital about patient safety and medicines across the interface

Want to see one of your photos on the front cover of EJHP?

Do you see yourself as the next Annie Liebovitz or David Bailey? We're looking for photographs that represent the role of the modern pharmacist, is it people, pills, robots or something completely different?

Images can be in any standard format, but need to have a minimum resolution of 300 dpi and you would need to own the copyright or have permission for the image to be used.

Submit your photos for consideration to: info.ejhp@bmjgroup.com

Invitation to contribute to EJHP

We'd love to hear from you if you would like to contribute to the journal.

EJHP is a great medium for your work and publication can help you in your career. We know that writing a paper can be a daunting task and we are here to help. If you are not sure if you have a suitable topic, the journal Editor in Chief , Phil Wiffen, is always happy to discuss potential publications and give support to first time authors.

Phil Wiffen, Pain Research Unit, Churchill Hospital, Old Road, Oxford OX3 7LE, UK;
phil.wiffen at dcn dot ox dot ac dot uk

Source

EJHP

“The Dublin Innovation Declaration” manifesto: Ten point declaration to create more wealth, better welfare and improved wellbeing with Open Innovation 2.0

The Irish presidency conference Open Innovation 2.0 – Sustainable Economy & Society in Dublin welcomed over 75 international experts who addressed more than 350 delegates from around the world, highlighting how economic growth and job creation can be generated by modern innovation and technology. The major two day international conference closed in Dublin Castle with overwhelming agreement on the drafting of “The Dublin Innovation Declaration”. This ten point declaration, drafted with the intention of harnessing innovation and technology to bring about job creation, will be presented to José Manuel Barroso, President of the European Commission.

Presenting the declaration to the conference, Prof Martin Curley, Chairman OISPG & Vice President, Intel Labs Europe, Intel Corporation called on those present to support the ideals and mission of the declaration. “With the support of the delegates and speakers here, at the end of what has been an enlightening and very positive two days of discussion, we have co-created an innovation manifesto which can now bring real change to Europe by creating more wealth, better welfare and improved wellbeing."

Mr Bror Salmelin, Advisor, Innovation Systems from the European Commission highlighted the new era for creating European innovation ecosystems for sustainable wealth and growth. ''This conference was a convergence point for a journey together, building upon past work and creating a path for future. Open innovation is all about making things happen. Open innovation 2.0 is about creating a European Innovation Ecosystem for jobs and growth", said Salmelin. In his opinion this all calls for action, for courage to try and experiment on topics, innovation processes and environments. "I am glad that our new Horizon 2020 enables and encourages this new approach, and of course a more holistic set of actions are needed. The Dublin Innovation Declaration is an excellent basis to go forward for the new www, expressed well by Venkat Ramaswamy: Wealth, welfare and well-being", claimed Salmelin.

“This conference, and The Dublin Innovation Declaration, has drawn attention to one of the most crucial elements of economic recovery – how to harness innovation and technology to bring about job creation. The key to job growth in this economy lies in innovation and we welcome the development of this significant declaration in Dublin, positioning the city and the country to take the lead on embracing innovation,” commented Peter Finnegan, Director of Office of International Relations and Economy, Dublin City Council. “

The Dublin Innovation Declaration” will seek to position Open Innovation 2.0 as the next new official innovation approach of the European Union, highlighting the importance of adopting and embracing innovation and technology to stimulate economic growth and generate job creation in Ireland and across the EU. Key points in the declaration presented to delegates included: common understanding and literacy for modern innovation systems and the various characteristics in it making it work also in practise, a call to move from European Research Area to European Innovation Ecosystem; raising awareness of the importance of creating incentives to encourage openness to innovation and experimentation; recognising honourable failure as a positive; stimulate high expectation entrepreneurs; foster the essential collaboration between citizens, businesses, universities and government; and an overall call to create an EU Innovation Strategy based on our strong assets, including the citizens in the quadruple helix innovation model. This requires leadership and courage, and the Innovation Luminary Awards would become an annual event within the European Calendar to recognise thought and action leadership in innovation.

The Open Innovation 2.0 Conference was organised under the patronage of the Irish Presidency of the European Union 2013 by the OISPG Group, the European Commission, Intel Labs Europe Dublin City Council, and Trinity College Dublin. The Conference delegates and speakers were addressed in video greetings by the President José Manuel Barroso and Vice President Neelie Kroes and Commissioners Androulla Vassilou and Máire Geoghegan-Quinn. 'I would like to congratulate the EU Open Innovation Strategy and Policy Group, together with the Irish Presidency, for organising this "Open Innovation two point zero" conference. […] The Horizon 2020 funding programme will represent a major step forward by bringing together, in one single programme, all research and innovation actions, right through to commercialisation […] By working together, Open Innovation can unleash Europe's creativity and providing new, user-driven products and services', said President Barroso.

Related Documents:
Open Innovation 2.0 - Dublin Innovation Declaration

Source

Digital Agenda for Europe

eHealth Week 2013: eHealth networking event of the year

Global decision makers from European public and private healthcare will be meeting High Level European Ministers and EU Commissioners, like Vice-President Neelie Kroes (Digital Agenda for Europe) and Commissioner Geoghegan-Quinn (Research, Innovation and Science). They will be joined by over 2,500 international delegates.

All of this combined, it's safe to say: This is the Health IT networking event of the year.

Taking place May 13th – 15th at The Convention Centre Dublin, eHealth Week 2013 will be showcasing the world’s most cutting edge Health IT technology and helping deliver the views and ideas of the worlds Health IT elite.

The eHealth marketplace will be open to all attendees and will provide real opportunities for doing business through the speaker’s corner, the device demo area, networking and the buzz of the Matchmaking meetings.

Investment in Action

eHealth Week wants to encourage the continuous investment in Health IT worldwide. This is in an effort to improve patient care and get a handle on rising medical costs.

In this respect it’s becoming ever more important that governments take advantage of cloud computing, mobile devices, ePortals, wireless telemetry equipment and automated pharmacy equipment.

In the past year alone Turkey along with the Scandinavian countries have led a phenomenal trend of large scale investments into the Health IT sector. But it’s not all Europe, the US has seen a 370% increase in Health IT investment in 2012 over 2011.

Governments are spending money on Health IT due to the certainty it will save money in the future. Make sure your company is represented at eHealth Week 2013, Europe’s premier Health IT networking event.

More info and the programme at www.ehealthweek.org 

Please join the pre-event networking and get the latest updates on Twitter: @EU_eHealthweek, #eHW13

We're also on Facebook.

 

More information

 

See also: 

Retweet this

Sources


http://ec.europa.eu/digital-agenda/en/news/eu-and-us-step-cooperation-ehealth-it

http://worldofhealthit.org/2013/

99% of hospital pharmacist experience difficulties with medicines shortages in past year

The European Association of Hospital Pharmacists (EAHP) has published headline results of a recent survey that reveals 99% of responding hospital pharmacists say they have experienced difficulties with medicines shortages in the past year.

With over 300 respondents from 27 countries, the survey also uncovered that 63% of hospital pharmacists report medicines shortages to be a weekly, sometimes daily, occurrence. 77% consider that problem has become worse in the last year.

Announcing the results at a reception in the European Parliament on access to medicines, EAHP President Dr Roberto Frontini said: “These headline results confirm what I have increasingly heard from our members across Europe: that the shortages problem is widespread, doesn’t respect national borders, and urgently requires attention if patient care and health services are not to suffer. Managing shortages and trying to source supply distracts pharmacists from other core tasks, places burden on support staff and can increase stress and workload in the pharmacy environment with consequent impacts on the risk of error. Substitution of medicines in case of shortage of formulary drugs can also confuse doctors and nurses, further raising risks to patient safety. I want to take this opportunity at the European Parliament to call on all partners to work together in identifying and enacting solutions. This includes industry and supply chain actors, regulatory authorities, and all health professions involved in medicines. I also believe there is a role for the European Commission in bringing Governments and others together on this issue.”

EAHP will publish the full results of its surveys at its forthcoming Congress in Paris, 13-15th March, 2013.

Source

EAHP

Adoption of EUCERD Recommendations on European Rare Disease Reference Networks promotes access to diagnostics and care

At the seventh meeting of the European Union Committee of Experts on Rare Diseases (EUCERD) on 31 January 2013 in Luxembourg, the EUCERD document Recommendations on Rare Disease European Reference Networks was unanimously adopted.

EURORDIS has been involved in the reflection process on Centres of Expertise and European Reference Networks from the beginning, and EURORDIS representatives at the EUCERD actively participated in the elaboration of the EUCERD Recommendations.

Learn more

Source

EURORDIS

Europe for patients: Common rules on medical prescriptions when travelling to another EU country

The Commission adopted pan-EU rules on a minimum list of elements to be included in a medical prescription taken by a patient travelling from one EU country to another. The provisions for a common way to identify the patient, the prescriber and the prescribed product, are to be put into national law by the Member States by 25 October 2013. Coordination of medical prescriptions for both medicinal products (pharmaceuticals) and medical devices will improve the authentication of cross-border prescriptions and translate into an estimated extra 200 000 prescriptions dispensed every year, benefiting patients and health authorities by avoiding delays, interruptions in treatment and extra costs.

Mr Tonio Borg, European Commissioner for Health and Consumer Policy, said: "Last year, the Commission adopted legislation on patients' rights in cross-border healthcare. Today's adoption of a code of practice for cross-border prescriptions is an essential step in achieving the main goal of this legislation: ensuring that patients' rights to access good quality treatment across EU borders becomes a reality. These rules will help secure that patients travelling to another Member State get the medicine they need in the country where they are thanks to clear cross-border prescriptions".

Solving real-life problems

Overall, the number of cross-border prescriptions is estimated to be low, around 2,3 million per year – which translates to between 0.02% and 0.04% of all prescriptions in the EU. Nevertheless, for specific groups of patients, improving the recognition of cross-border prescriptions makes an important difference. For example, for patients with chronic diseases wishing to travel to another country, for patients living in border regions or smaller Member States for whom filling out a cross-border prescription is a necessity and for patients with a rare disease, where the best expertise can be found across a border.

With the current diversity of prescriptions across the EU, it is estimated that over half of patients would have problems with their prescription being recognised in another EU country. 

The guidelines in practice

The new rules on Prescriptions take the form of an Implementing Directive. They introduce a common set of descriptive elements to help identify prescribers, patients and prescribed products. They do not, however, deal with the appearance, format or language of the prescription. Nor do they preclude further elements, in line with local practices, being added by prescribers. These common elements are limited to cross-border prescriptions requested by the patient, not prescriptions used within a country (unless a Member State so chooses).

National Contact Points, established under the Cross-border healthcare Directive will inform patients on the right to travel with a cross-border prescription when visiting another Member State as well as the minimum list of elements that it should contain.

For more information on cross-border healthcare, including prescriptions:

http://ec.europa.eu/health/cross_border_care/policy/index_en.htm

Source

http://europa.eu/rapid/press-release_IP-12-1422_en.htm